Investor mix
6 investors on record; lead investors include SR One, Vida Ventures, Platanus, Janus Henderson Investors.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Other / undisclosed | 3 | 50% |
Developer of anti-IgE therapy for allergic disease treatment
6 investors on record; lead investors include SR One, Vida Ventures, Platanus, Janus Henderson Investors.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Other / undisclosed | 3 | 50% |